RT Journal Article
SR Electronic
T1 Efficacy of administration of coagulation factor XIII with definitive surgery for multiple intractable enterocutaneous fistulae in a patient with decreased factor XIII activity
JF BMJ Case Reports
FD BMJ Publishing Group Ltd
SP bcr0920103342
DO 10.1136/bcr.09.2010.3342
VO 2011
A1 Susumu Saigusa
A1 Takeshi Yamamura
A1 Koji Tanaka
A1 Masaki Ohi
A1 Aya Kawamoto
A1 Minako Kobayashi
A1 Yasuhiro Inoue
A1 Masato Kusunoki
YR 2011
UL http://casereports.bmj.com/content/2011/bcr.09.2010.3342.abstract
AB Enterocutaneous fistulae (ECF) are challenging problem commonly encountered by surgeons and cause significant complications. They not only prolong hospital stay, but also restrict a patient’s activities of daily living. The authors report a case of successful treatment of multiple intractable ECF in a patient with decreased coagulation factor XIII (FXIII) activity using intravenous FXIII treatment. A 74-year-old man with multiple ECF was referred. Although no factors involved in impaired wound were initially identified, he developed ECF after multiple surgical interventions with repeated wound dehiscence. FXIII activity was below the normal value. A definitive operation was performed and FXIII was administrated for 5 days postoperatively. There was no fistula recurrence and no other complications. Preoperative assessment of factors related to wound repair, such as FXIII activity, may be important for patients with wound dehiscence and subsequent fistula development and should be considered in patients who are resistant to standard treatments.